Carrie Jones

September 27, 2018

Innovative strategies crucial in opioid epidemic response

Reining in the nation’s opioid epidemic will require diverse and innovative strategies ranging from drug discovery to “policy translation,” according to speakers at a recent Vanderbilt Faculty Cutting-edge Discovery Lecture.

By Bill Snyder
elderly Asian mother and adult daughter
August 7, 2017

Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

By Bill Snyder
March 21, 2016

Putting schizophrenia to bed

A new compound developed at Vanderbilt treats multiple symptoms of schizophrenia in an animal model, without causing sedation.

By VUMC News and Communications
September 30, 2011

Drug-like molecules aimed at improving treatment of Parkinson’s

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson’s treatments with fewer side effects.

By Bill Snyder
March 11, 2011

Neuroscience drug discovery center opens at Vanderbilt

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson’s disease, schizophrenia and other disorders of the brain.

By Bill Snyder